Sfoglia per Autore
Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study.
2002-01-01 Cazzullo, Cl; Sacchetti, Emilio; Galluzzo, A; Panariello, A; Adorni, A; Pegoraro, M; Bosis, S; Colombo, F; Trabattoni, D; Zagliani, A; Clerici, M.
Improving the chance of recovery from the short- and long-term consequences of depression.
2003-01-01 Moller, Hj; Demyttenaere, K; Sacchetti, Emilio; Rush, Aj; Montgomery, S. A.
Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report.
2003-01-01 Sacchetti, Emilio; Valsecchi, Paolo
Panic disorder with and without comorbidity: data on epidemiology, course and treatment outcome.
2004-01-01 Sacchetti, Emilio; Valsecchi, Paolo; Bonomi, S.
Diffusion Tensor Imaging of the corpus callosum in "drug naive" schizophrenic patients
2004-01-01 Gasparotti, Roberto; Liserre, R; Mardighian, D; Colleoni, M; Regini, A; Sacchetti, Emilio
Diffusion Tensor Imaging of the corpus callosum in “drug naïve” schizophrenic patients
2004-01-01 Gasparotti, Roberto; R., Liserre; D., Mardighian; E., Negrini; Sacchetti, Emilio
Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial.
2004-01-01 Sacchetti, Emilio; Panariello, A; Regini, C; Valsecchi, Paolo
Comparison of quetiapine, olanzapine and risperidone in schizophrenia.
2004-01-01 Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo; Agrimi, Emilia; Mencacci, C.
Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia.
2004-01-01 Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo; Agrimi, Emilia; Mencacci, C.
Comparison of quetiapine, olanzapine and risperidone in a randomized study in patients with schizophrenia.
2004-01-01 Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo
Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study.
2004-01-01 Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo; Agrimi, Emilia; Mencacci, C.
Relationship of IQ to neuropsychological tasks involving prefrontal cortex in schizophrenia.
2004-01-01 Galluzzo, Alessandro; Gelpi, F.; Mosca, A.; Barlati, S.; Bonomi, S.; Valsecchi, Paolo; Sacchetti, Emilio
Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia.
2004-01-01 Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo; Agrimi, Emilia; Mencacci, C.
Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure.
2005-01-01 Sacchetti, Emilio; Turrina, Cesare; Parrinello, Giovanni; Brignoli, O; Stefanini, G; Mazzaglia, G.
Cardiovascular and neurohumoral effects of the administration of reboxetine to health volunteers.
2005-01-01 Nodari, Savina; Metra, Marco; Trussardi, E; Madureri, A; Manerba, Alessandra; Sacchetti, Emilio; DEI CAS, Livio
DIRECT TRANSITION TO LONG-ACTING RISPERIDONE--ANALYSIS OF LONG-TERM EFFICACY.
2005-01-01 Kissling, W; Heres, S; Lloyd, K; Sacchetti, Emilio; Bouhours, P; Medori, R; Llorca, P. M.
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies.
2005-01-01 Moller, Hj; Llorca, Pm; Sacchetti, Emilio; Martin, Sd; Medori, R; Parellada, E; STORMI STUDY, Group
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study
2006-01-01 Gennarelli, Massimo; Bocchio Chiavetto, L; Valsecchi, Paolo; Scassellati, C; Pasqualetti, P; Bonvicini, C; Corsini, P; Rossi, G; Cesana, Bruno Mario; Barlati, Sergio; Sacchetti, Emilio
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4
2006-01-01 Magri, Chiara; Gardella, Rita; Imperadori, L; Podavini, D; Iatropoulos, P; Barlati, Sergio; Valsecchi, Paolo; Bonvicini, C; Gennarelli, Massimo; Sacchetti, Emilio; Barlati, S.
Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia
2006-01-01 Turrina, Cesare; Valsecchi, Paolo; Bonomi, S; Corsini, P; Cacciani, P; Medea, G; Brignoli, O; Sacchetti, Emilio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. | 1-gen-2002 | Cazzullo, Cl; Sacchetti, Emilio; Galluzzo, A; Panariello, A; Adorni, A; Pegoraro, M; Bosis, S; Colombo, F; Trabattoni, D; Zagliani, A; Clerici, M. | |
| Improving the chance of recovery from the short- and long-term consequences of depression. | 1-gen-2003 | Moller, Hj; Demyttenaere, K; Sacchetti, Emilio; Rush, Aj; Montgomery, S. A. | |
| Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report. | 1-gen-2003 | Sacchetti, Emilio; Valsecchi, Paolo | |
| Panic disorder with and without comorbidity: data on epidemiology, course and treatment outcome. | 1-gen-2004 | Sacchetti, Emilio; Valsecchi, Paolo; Bonomi, S. | |
| Diffusion Tensor Imaging of the corpus callosum in "drug naive" schizophrenic patients | 1-gen-2004 | Gasparotti, Roberto; Liserre, R; Mardighian, D; Colleoni, M; Regini, A; Sacchetti, Emilio | |
| Diffusion Tensor Imaging of the corpus callosum in “drug naïve” schizophrenic patients | 1-gen-2004 | Gasparotti, Roberto; R., Liserre; D., Mardighian; E., Negrini; Sacchetti, Emilio | |
| Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial. | 1-gen-2004 | Sacchetti, Emilio; Panariello, A; Regini, C; Valsecchi, Paolo | |
| Comparison of quetiapine, olanzapine and risperidone in schizophrenia. | 1-gen-2004 | Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo; Agrimi, Emilia; Mencacci, C. | |
| Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia. | 1-gen-2004 | Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo; Agrimi, Emilia; Mencacci, C. | |
| Comparison of quetiapine, olanzapine and risperidone in a randomized study in patients with schizophrenia. | 1-gen-2004 | Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo | |
| Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study. | 1-gen-2004 | Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo; Agrimi, Emilia; Mencacci, C. | |
| Relationship of IQ to neuropsychological tasks involving prefrontal cortex in schizophrenia. | 1-gen-2004 | Galluzzo, Alessandro; Gelpi, F.; Mosca, A.; Barlati, S.; Bonomi, S.; Valsecchi, Paolo; Sacchetti, Emilio | |
| Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia. | 1-gen-2004 | Sacchetti, Emilio; Valsecchi, Paolo; Regini, C.; Galluzzo, Alessandro; Cacciani, Paolo; Agrimi, Emilia; Mencacci, C. | |
| Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure. | 1-gen-2005 | Sacchetti, Emilio; Turrina, Cesare; Parrinello, Giovanni; Brignoli, O; Stefanini, G; Mazzaglia, G. | |
| Cardiovascular and neurohumoral effects of the administration of reboxetine to health volunteers. | 1-gen-2005 | Nodari, Savina; Metra, Marco; Trussardi, E; Madureri, A; Manerba, Alessandra; Sacchetti, Emilio; DEI CAS, Livio | |
| DIRECT TRANSITION TO LONG-ACTING RISPERIDONE--ANALYSIS OF LONG-TERM EFFICACY. | 1-gen-2005 | Kissling, W; Heres, S; Lloyd, K; Sacchetti, Emilio; Bouhours, P; Medori, R; Llorca, P. M. | |
| Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies. | 1-gen-2005 | Moller, Hj; Llorca, Pm; Sacchetti, Emilio; Martin, Sd; Medori, R; Parellada, E; STORMI STUDY, Group | |
| -G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study | 1-gen-2006 | Gennarelli, Massimo; Bocchio Chiavetto, L; Valsecchi, Paolo; Scassellati, C; Pasqualetti, P; Bonvicini, C; Corsini, P; Rossi, G; Cesana, Bruno Mario; Barlati, Sergio; Sacchetti, Emilio | |
| Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 | 1-gen-2006 | Magri, Chiara; Gardella, Rita; Imperadori, L; Podavini, D; Iatropoulos, P; Barlati, Sergio; Valsecchi, Paolo; Bonvicini, C; Gennarelli, Massimo; Sacchetti, Emilio; Barlati, S. | |
| Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia | 1-gen-2006 | Turrina, Cesare; Valsecchi, Paolo; Bonomi, S; Corsini, P; Cacciani, P; Medea, G; Brignoli, O; Sacchetti, Emilio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile